A phase Ib/II study evaluating Fruquintinib plus 5-Fluorouracil/Leucovorin (5FU/LV) beyond progression on Fruquintinib monotherapy in metastatic colorectal cancer
收藏NIAID Data Ecosystem2026-03-11 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2693103
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: experimental group:Fruquintinib plus 5-Fluorouracil /Leucovorin
Primary outcome(s): recommended phase 2 dose (RP2D);6-month overall survival rate
Study Design: Single arm
创建时间：
2020-04-15
